1. Home
  2. SQM vs VTRS Comparison

SQM vs VTRS Comparison

Compare SQM & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sociedad Quimica y Minera S.A.

SQM

Sociedad Quimica y Minera S.A.

HOLD

Current Price

$80.86

Market Cap

17.6B

Sector

Industrials

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.35

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQM
VTRS
Founded
1968
1961
Country
Chile
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6B
14.2B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
SQM
VTRS
Price
$80.86
$13.35
Analyst Decision
Hold
Hold
Analyst Count
9
6
Target Price
$62.61
$11.50
AVG Volume (30 Days)
1.1M
8.6M
Earning Date
03-03-2026
02-26-2026
Dividend Yield
2.72%
3.79%
EPS Growth
N/A
N/A
EPS
1.84
N/A
Revenue
$4,326,111,000.00
$14,124,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.11
$1.18
P/E Ratio
$42.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.36
$6.85
52 Week High
$78.28
$12.85

Technical Indicators

Market Signals
Indicator
SQM
VTRS
Relative Strength Index (RSI) 79.23 81.40
Support Level $73.11 $12.19
Resistance Level $75.79 $12.68
Average True Range (ATR) 1.76 0.29
MACD 0.52 0.03
Stochastic Oscillator 94.40 98.64

Price Performance

Historical Comparison
SQM
VTRS

About SQM Sociedad Quimica y Minera S.A.

Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: